Persistent catatonia during benzodiazepine treatment can coexist with an active neurological disease.
What the supplied research shows
A case report described a young woman with anti-NMDA receptor encephalitis and severe psychiatric and catatonic symptoms. The course included immunotherapies and psychiatric medicines, including clonazepam, without adequate improvement. Her condition improved substantially after twelve electroconvulsive treatments. The report placed that response in the context of earlier case literature.
What it cannot establish
Multiple treatments, disease evolution and the absence of a comparison group prevent assigning the entire recovery to one intervention. The case does not establish that clonazepam is generally ineffective for catatonia or that a positive antibody test explains every symptom without clinical correlation.
Forensic interpretation and case review
When assessing a prolonged neuropsychiatric presentation, reconstruct both disease-directed and symptom-directed treatment. Distinguish continued immobility or mutism from medication-induced unconsciousness, and examine the neurological workup. An expert should not infer benzodiazepine toxicity solely from altered behavior during a complex encephalitis course. This report demonstrates the importance of competing mechanisms and longitudinal assessment; it cannot supply a single-drug explanation for the whole admission.
Source and related reading
Source: supplied full-text paper, PMC8285755. Findings are paraphrased; the forensic discussion is an interpretation of the evidence.
Related: Lorazepam Improvement in Wilson’s Disease Catatonia Did Not Replace the Copper-Metabolism Diagnosis.
Leave a Reply